ÂÜÀòÂÒÂ×

Aileen Murphy is an experienced professional in the oncology and biostatistics fields, currently serving as Vice President and Transition Lead for Late Stage Oncology at Pfizer since December 2023. Prior to this role, Aileen worked as a Leadership Coach, certified by Hudson and ICF, beginning in October 2020. Aileen's extensive tenure at Seagen from April 2007 to December 2023 included positions such as Vice President of Development Integration & Operations and Executive Director roles in Operations and Biometrics. Aileen's early career includes significant positions at ZymoGenetics, ICOS Corporation, and PathoGenesis, where Aileen developed expertise in biostatistics and data management.